首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Role of Artificial Intelligence in Anesthesia: Revolutionizing Patient Safety and Care. 人工智能在麻醉中的作用:革新患者安全和护理。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_50_23
Ram Kumar Garg
{"title":"Role of Artificial Intelligence in Anesthesia: Revolutionizing Patient Safety and Care.","authors":"Ram Kumar Garg","doi":"10.4103/jrpp.jrpp_50_23","DOIUrl":"10.4103/jrpp.jrpp_50_23","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"68"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Sequential Organ Failure Assessment Score, Acute Physiology and Chronic Health Evaluation II, Modified Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology Score II and Poisoning Severity Score for Outcome Prediction of Pesticide Poisoned Patients Admitted to the Intensive Care Unit. 比较顺序器官衰竭评估评分、急性生理学和慢性健康评估 II、改良急性生理学和慢性健康评估 II、简化急性生理学评分 II 和中毒严重程度评分,以预测入住重症监护室的农药中毒患者的预后。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_43_23
Gholamali Dorooshi, Shiva Samsamshariat, Farzad Gheshlaghi, Shafeajafar Zoofaghari, Akbar Hasanzadeh, Saeed Abbasi, Nastaran Eizadi-Mood

Objective: This study aimed to assess the severity of poisoning, various scoring systems, including Sequential Organ Failure Assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II), Simplified Acute Physiology Score (SAPS II), Modified APACHE II, and poisoning severity score (PSS) were used. In this study, we compared the predictive value of these scoring systems on the outcome of pesticide-poisoned patients.

Methods: This is a cross-sectional study of pesticide-poisoned patients (140 patients) who were admitted to the intensive care unit (ICU) of Khorshid Hospital, Isfahan, Iran, between January 2015 and 2019. The area under the receiver operating characteristic (AUC) curve and the predictive value of scoring systems were compared.

Findings: Poisoning was higher in the male population (72.8%). The causes of poisoning were paraquat, (38.6%), aluminum phosphide, (32.1%), and organophosphate, (29.3%). The mean age of the patients was 33.9 years. Most patients (79.3%) attempted suicide. The mortality rate was 46.43%. The mean of "SOFA score," "APACHE II," "SAPS II," "Modified APACHE II," and "PSS" was 5.9; 15.7; 30.02; 15.8; and 1.9, respectively. There was a significant difference in the mean of all scoring systems for outcome prediction. Among all scoring systems, the SAPS II score with the cutoff point (16.5) had the best criteria for outcome prediction (AUC (0.831 ± 0.037), sensitivity (83.1%, 95% confidence interval [CI]: [71.7-91.2]), specificity (75.7%, 95% CI: [64.3-84.9]), positive predictive values (75.0%, 95% CI: [66.4-82.0]), negative predictive values (83.6%, 95% CI: [74.5-89.9]).

Conclusion: The SAPS II scoring system may be a suitable indicator for outcome predictions in pesticide-poisoned patients in the ICU.

研究目的本研究旨在评估中毒的严重程度,使用了多种评分系统,包括序贯器官衰竭评估(SOFA)评分、急性生理学和慢性健康评估 II(APACHE II)、简化急性生理学评分(SAPS II)、改良 APACHE II 和中毒严重程度评分(PSS)。在本研究中,我们比较了这些评分系统对农药中毒患者预后的预测价值:这是一项横断面研究,研究对象为 2015 年 1 月至 2019 年期间入住伊朗伊斯法罕 Khorshid 医院重症监护室(ICU)的农药中毒患者(140 名)。比较了接受者操作特征曲线下面积(AUC)和评分系统的预测价值:男性中毒率较高(72.8%)。中毒原因为百草枯(38.6%)、磷化铝(32.1%)和有机磷(29.3%)。患者的平均年龄为 33.9 岁。大多数患者(79.3%)试图自杀。死亡率为 46.43%。SOFA 评分"、"APACHE II"、"SAPS II"、"改良 APACHE II "和 "PSS "的平均值分别为 5.9、15.7、30.02、15.8 和 1.9。所有评分系统对结果预测的平均值均有明显差异。在所有评分系统中,以 16.5 为分界点的 SAPS II 评分具有最佳的结果预测标准(AUC(0.831 ± 0.037)、灵敏度(83.1%,95% 置信区间 [CI]:[71.7-91.2])、特异性(75.7%,95% CI:[64.3-84.9])、阳性预测值(75.0%,95% CI:[66.4-82.0])、阴性预测值(83.6%,95% CI:[74.5-89.9]):SAPSⅡ评分系统可能是预测重症监护室农药中毒患者预后的合适指标。
{"title":"Comparing Sequential Organ Failure Assessment Score, Acute Physiology and Chronic Health Evaluation II, Modified Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology Score II and Poisoning Severity Score for Outcome Prediction of Pesticide Poisoned Patients Admitted to the Intensive Care Unit.","authors":"Gholamali Dorooshi, Shiva Samsamshariat, Farzad Gheshlaghi, Shafeajafar Zoofaghari, Akbar Hasanzadeh, Saeed Abbasi, Nastaran Eizadi-Mood","doi":"10.4103/jrpp.jrpp_43_23","DOIUrl":"10.4103/jrpp.jrpp_43_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the severity of poisoning, various scoring systems, including Sequential Organ Failure Assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II), Simplified Acute Physiology Score (SAPS II), Modified APACHE II, and poisoning severity score (PSS) were used. In this study, we compared the predictive value of these scoring systems on the outcome of pesticide-poisoned patients.</p><p><strong>Methods: </strong>This is a cross-sectional study of pesticide-poisoned patients (140 patients) who were admitted to the intensive care unit (ICU) of Khorshid Hospital, Isfahan, Iran, between January 2015 and 2019. The area under the receiver operating characteristic (AUC) curve and the predictive value of scoring systems were compared.</p><p><strong>Findings: </strong>Poisoning was higher in the male population (72.8%). The causes of poisoning were paraquat, (38.6%), aluminum phosphide, (32.1%), and organophosphate, (29.3%). The mean age of the patients was 33.9 years. Most patients (79.3%) attempted suicide. The mortality rate was 46.43%. The mean of \"SOFA score,\" \"APACHE II,\" \"SAPS II,\" \"Modified APACHE II,\" and \"PSS\" was 5.9; 15.7; 30.02; 15.8; and 1.9, respectively. There was a significant difference in the mean of all scoring systems for outcome prediction. Among all scoring systems, the SAPS II score with the cutoff point (16.5) had the best criteria for outcome prediction (AUC (0.831 ± 0.037), sensitivity (83.1%, 95% confidence interval [CI]: [71.7-91.2]), specificity (75.7%, 95% CI: [64.3-84.9]), positive predictive values (75.0%, 95% CI: [66.4-82.0]), negative predictive values (83.6%, 95% CI: [74.5-89.9]).</p><p><strong>Conclusion: </strong>The SAPS II scoring system may be a suitable indicator for outcome predictions in pesticide-poisoned patients in the ICU.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"49-57"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance Challenges in a Newly Established Clean Room at Omid Hospital, Isfahan, Iran: A Descriptive Study. 伊朗伊斯法罕市奥米德医院新建洁净室面临的性能挑战:描述性研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_40_23
Mehrnaz Vaez, Mehran Sharifi, Sahar Karimi, Azadeh Moghaddas

Objective: This study aimed to comprehensively assess the challenges faced by a newly established clean room in the oncology center of Omid Hospital, Isfahan, Iran, one of the first of its kind in the country. The research also sought to identify the underlying causes of these challenges and propose potential solutions to address them.

Methods: A 6-month cross-sectional study was conducted from December 2021 to May 2022. International guidelines such as British Columbia Cancer Agencies' guideline of hazardous drugs, the National Institute for Occupational Safety and Health guideline for working with hazardous drugs, and United States pharmacopeia related to cleanroom performance were studied, translated, and summarized into a checklist. The staff performance in Omid Hospital's clean room was compared to the data collection form, and all medication errors were documented and analyzed. The study also explained the underlying causes of these challenges and proposed potential solutions.

Findings: Among 1005 chemotherapy regimens, 836 errors were detected, stemming from issues such as engineering and construction challenges, lack of human resources and essential equipment, and budgetary constraints.

Conclusion: Despite the involvement of a trained oncology clinical pharmacist, Omid Hospital's cleanroom faces significant challenges within the medical and hospital system, leading to non-standard challenges. The study recommends multidisciplinary approaches in the hospital to mitigate these challenges and improve cleanroom performance.

研究目的本研究旨在全面评估伊朗伊斯法罕市奥米德医院肿瘤中心新建立的洁净室所面临的挑战。研究还试图找出这些挑战的根本原因,并提出潜在的解决方法:从 2021 年 12 月到 2022 年 5 月进行了为期 6 个月的横断面研究。对不列颠哥伦比亚省癌症机构的危险药品指南、美国国家职业安全与健康研究所的危险药品工作指南以及美国药典等与洁净室性能相关的国际指南进行了研究、翻译,并总结成一份检查表。将奥米德医院洁净室工作人员的表现与数据收集表进行了比较,并记录和分析了所有用药错误。研究还解释了这些挑战的根本原因,并提出了潜在的解决方案:在 1005 个化疗方案中,发现了 836 个错误,原因包括工程和建筑方面的挑战、缺乏人力资源和必要设备以及预算限制等:尽管有训练有素的肿瘤临床药剂师参与,但奥米德医院的洁净室在医疗和医院系统中仍面临重大挑战,导致了非标准的难题。研究建议医院采用多学科方法来减轻这些挑战,提高洁净室的性能。
{"title":"Performance Challenges in a Newly Established Clean Room at Omid Hospital, Isfahan, Iran: A Descriptive Study.","authors":"Mehrnaz Vaez, Mehran Sharifi, Sahar Karimi, Azadeh Moghaddas","doi":"10.4103/jrpp.jrpp_40_23","DOIUrl":"10.4103/jrpp.jrpp_40_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to comprehensively assess the challenges faced by a newly established clean room in the oncology center of Omid Hospital, Isfahan, Iran, one of the first of its kind in the country. The research also sought to identify the underlying causes of these challenges and propose potential solutions to address them.</p><p><strong>Methods: </strong>A 6-month cross-sectional study was conducted from December 2021 to May 2022. International guidelines such as British Columbia Cancer Agencies' guideline of hazardous drugs, the National Institute for Occupational Safety and Health guideline for working with hazardous drugs, and United States pharmacopeia related to cleanroom performance were studied, translated, and summarized into a checklist. The staff performance in Omid Hospital's clean room was compared to the data collection form, and all medication errors were documented and analyzed. The study also explained the underlying causes of these challenges and proposed potential solutions.</p><p><strong>Findings: </strong>Among 1005 chemotherapy regimens, 836 errors were detected, stemming from issues such as engineering and construction challenges, lack of human resources and essential equipment, and budgetary constraints.</p><p><strong>Conclusion: </strong>Despite the involvement of a trained oncology clinical pharmacist, Omid Hospital's cleanroom faces significant challenges within the medical and hospital system, leading to non-standard challenges. The study recommends multidisciplinary approaches in the hospital to mitigate these challenges and improve cleanroom performance.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"33-43"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of an Herbal Preparation (Atomy's HemoHIM®) against Ventilator-associated Pneumonia: A Randomized Controlled Clinical Trial. 草药制剂(Atomy's HemoHIM®)对呼吸机相关肺炎的疗效:随机对照临床试验。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_9_23
Ghazal Khamooshpour, Hossein Mahjubipour, Shadi Farsaei

Objective: Despite the standard guideline recommendations to prevent ventilator-associated pneumonia (VAP), it has remained one of the common lung infections in the intensive care unit (ICU). This clinical trial was designed to evaluate the effect of HemoHIM®, a mixture of traditional Korean medicinal plants, on preventing VAP in ICU patients.

Methods: This randomized controlled clinical trial was conducted on mechanically ventilated adult ICU patients with a clinical pulmonary infection score of VAP ≤6 in the first 48 h of ventilation. Patients in the intervention group received a packet of HemoHIM daily and orally for 7 days in addition to standard prevention strategies. However, in the control group, only standard prevention strategies were carried out. All patients were followed daily for VAP incidence for 14 days.

Findings: The overall VAP incidence was 36.4 and 57.4 episodes per 1000 days of mechanical ventilation in the intervention and control groups, respectively (P = 0.041; odds ratio = 0.26; 95% confidence interval = 0.070-0.944). The median length of mechanical ventilation during study follow-up was significantly lower in the intervention than in the control group (P = 0.033). The number of pneumonia-free days during the study was considerably higher in the intervention group (P value of the log-rank test = 0.023).

Conclusion: According to the results of this study, the HemoHIM herbal supplement had beneficial effects in preventing the occurrence of VAP and significantly reduced the incidence of pneumonia in the intervention group. Further comprehensive research is required to draw more accurate conclusions.

目的:尽管标准指南建议预防呼吸机相关肺炎(VAP),但它仍然是重症监护病房(ICU)中常见的肺部感染之一。本临床试验旨在评估 HemoHIM®(一种韩国传统药用植物的混合物)对 ICU 患者预防 VAP 的效果:这项随机对照临床试验的对象是通气 48 小时内 VAP 临床肺部感染评分≤6 分的成人 ICU 机械通气患者。除标准预防策略外,干预组患者每天口服一包 HemoHIM,连续服用 7 天。而在对照组中,只实施了标准预防策略。对所有患者进行为期 14 天的 VAP 发生率每日随访:干预组和对照组的 VAP 总发生率分别为每 1000 天机械通气 36.4 次和 57.4 次(P = 0.041;几率比 = 0.26;95% 置信区间 = 0.070-0.944)。研究随访期间,干预组的机械通气时间中位数明显低于对照组(P = 0.033)。干预组研究期间无肺炎天数明显高于对照组(对数秩检验的 P 值 = 0.023):根据本研究的结果,HemoHIM 中药补充剂对预防 VAP 的发生有益处,并显著降低了干预组的肺炎发病率。要得出更准确的结论,还需要进一步的综合研究。
{"title":"Efficacy of an Herbal Preparation (Atomy's HemoHIM<sup>®</sup>) against Ventilator-associated Pneumonia: A Randomized Controlled Clinical Trial.","authors":"Ghazal Khamooshpour, Hossein Mahjubipour, Shadi Farsaei","doi":"10.4103/jrpp.jrpp_9_23","DOIUrl":"10.4103/jrpp.jrpp_9_23","url":null,"abstract":"<p><strong>Objective: </strong>Despite the standard guideline recommendations to prevent ventilator-associated pneumonia (VAP), it has remained one of the common lung infections in the intensive care unit (ICU). This clinical trial was designed to evaluate the effect of HemoHIM<sup>®</sup>, a mixture of traditional Korean medicinal plants, on preventing VAP in ICU patients.</p><p><strong>Methods: </strong>This randomized controlled clinical trial was conducted on mechanically ventilated adult ICU patients with a clinical pulmonary infection score of VAP ≤6 in the first 48 h of ventilation. Patients in the intervention group received a packet of HemoHIM daily and orally for 7 days in addition to standard prevention strategies. However, in the control group, only standard prevention strategies were carried out. All patients were followed daily for VAP incidence for 14 days.</p><p><strong>Findings: </strong>The overall VAP incidence was 36.4 and 57.4 episodes per 1000 days of mechanical ventilation in the intervention and control groups, respectively (<i>P</i> = 0.041; odds ratio = 0.26; 95% confidence interval = 0.070-0.944). The median length of mechanical ventilation during study follow-up was significantly lower in the intervention than in the control group (<i>P</i> = 0.033). The number of pneumonia-free days during the study was considerably higher in the intervention group (<i>P</i> value of the log-rank test = 0.023).</p><p><strong>Conclusion: </strong>According to the results of this study, the HemoHIM herbal supplement had beneficial effects in preventing the occurrence of VAP and significantly reduced the incidence of pneumonia in the intervention group. Further comprehensive research is required to draw more accurate conclusions.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"58-63"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the Prevalence of Contrast-associated Nephropathy and the Related Risk Factors in Patients Undergoing Elective Angioplasty. 研究择期血管成形术患者对比度相关性肾病的患病率及相关风险因素
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_1_24
Mehrnoush Dianatkhah, Samira Poursaeid, Ehsan Shirvani, Shirinsadat Badri

Objective: Contrast-associated nephropathy (CAN) is a sudden decrease in kidney function following contrast media administration. Considering the importance of CAN in the patient's outcome and the high prevalence of this complication in cardiac catheterizing centers, this study was designed to investigate the prevalence and the related risk factors of CAN in patients undergoing angioplasty in Chamran Heart Hospital, Isfahan, Iran, from January 2022 to June 2022.

Methods: The inclusion criteria were adult patients above 18 admitted for elective percutaneous coronary intervention (PCI). Patient demographic information, underlying diseases and medications, dehydration state, type and amount of contrast media, and serum levels of blood urea nitrogen (BUN) and serum creatinine (SrCr) at 24 and 72 h after contrast injection were all recorded.

Findings: Out of 340, 128 patients developed CAN after PCI, giving an incidence of 37.64%. Adjusted analysis showed a significant relation between age over 65, the amount of contrast media administered, and the use of furosemide with the incidence of CAN. However, adjusted logistic regression analysis failed to show any significant relationship between the risk of CAN and the hydration status of the patients at 24 and 48 h after receiving contrast media as diagnosed by BUN/SrCr >20.

Conclusion: The prevalence of CAN in this study was higher than in other studies since this high-risk population was under risk factors such as arterial injection of contrast material and a higher amount of contrast material administration. In addition, advanced age, volume of contrast material, and previous or concurrent furosemide administration were associated with an increased risk of CAN.

目的:造影剂相关肾病(CAN)是指使用造影剂后肾功能突然下降。考虑到造影剂相关性肾病对患者预后的重要性以及该并发症在心导管中心的高发病率,本研究旨在调查 2022 年 1 月至 2022 年 6 月期间在伊朗伊斯法罕市 Chamran 心脏医院接受血管成形术的患者中造影剂相关性肾病的发病率及相关风险因素:纳入标准:接受择期经皮冠状动脉介入治疗(PCI)的 18 岁以上成年患者。患者的人口统计学信息、基础疾病和用药情况、脱水状态、造影剂的类型和用量以及注射造影剂后 24 小时和 72 小时的血清尿素氮(BUN)和血清肌酐(SrCr)水平均被记录在案:在 340 例患者中,有 128 例患者在 PCI 术后发生 CAN,发生率为 37.64%。调整后的分析表明,年龄超过 65 岁、造影剂用量和使用呋塞米与 CAN 的发生率有显著关系。然而,调整后的逻辑回归分析未能显示 CAN 风险与患者接受造影剂后 24 和 48 小时的水合状态(根据 BUN/SrCr >20 诊断)之间有任何显著关系:本研究中 CAN 的发病率高于其他研究,因为高危人群存在动脉注射造影剂和造影剂用量较多等风险因素。此外,高龄、造影剂用量、之前或同时使用呋塞米也与 CAN 风险增加有关。
{"title":"Investigating the Prevalence of Contrast-associated Nephropathy and the Related Risk Factors in Patients Undergoing Elective Angioplasty.","authors":"Mehrnoush Dianatkhah, Samira Poursaeid, Ehsan Shirvani, Shirinsadat Badri","doi":"10.4103/jrpp.jrpp_1_24","DOIUrl":"10.4103/jrpp.jrpp_1_24","url":null,"abstract":"<p><strong>Objective: </strong>Contrast-associated nephropathy (CAN) is a sudden decrease in kidney function following contrast media administration. Considering the importance of CAN in the patient's outcome and the high prevalence of this complication in cardiac catheterizing centers, this study was designed to investigate the prevalence and the related risk factors of CAN in patients undergoing angioplasty in Chamran Heart Hospital, Isfahan, Iran, from January 2022 to June 2022.</p><p><strong>Methods: </strong>The inclusion criteria were adult patients above 18 admitted for elective percutaneous coronary intervention (PCI). Patient demographic information, underlying diseases and medications, dehydration state, type and amount of contrast media, and serum levels of blood urea nitrogen (BUN) and serum creatinine (SrCr) at 24 and 72 h after contrast injection were all recorded.</p><p><strong>Findings: </strong>Out of 340, 128 patients developed CAN after PCI, giving an incidence of 37.64%. Adjusted analysis showed a significant relation between age over 65, the amount of contrast media administered, and the use of furosemide with the incidence of CAN. However, adjusted logistic regression analysis failed to show any significant relationship between the risk of CAN and the hydration status of the patients at 24 and 48 h after receiving contrast media as diagnosed by BUN/SrCr >20.</p><p><strong>Conclusion: </strong>The prevalence of CAN in this study was higher than in other studies since this high-risk population was under risk factors such as arterial injection of contrast material and a higher amount of contrast material administration. In addition, advanced age, volume of contrast material, and previous or concurrent furosemide administration were associated with an increased risk of CAN.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"64-67"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Head-to-Head Comparison of Tazarotene and Calcitriol with or without Sequential Therapy in Mild-to-Moderate Psoriasis: A Randomized Open-label Study. 轻度至中度银屑病患者接受或不接受他扎罗汀和骨化三醇序贯疗法的头对头比较:一项随机开放标签研究
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-31 eCollection Date: 2023-04-01 DOI: 10.4103/jrpp.jrpp_10_23
Jaspreet Kaur Sidhu, Prithpal Singh Matreja, Ashwani Kumar Gupta, Amandeep Singh, Surjit Singh

Objective: Psoriasis is an autoimmune disease that causes rapid turnover of skin cells. It is a chronic disease that affects a patient's quality of life significantly and frequently requires long-term treatment. The study on sequential therapy with tazarotene 0.1% and calcitriol 0.0003% has not been tried so far; hence, we designed this study to compare the safety and efficacy of sequential therapy with tazarotene 0.1% cream and calcitriol 0.0003% ointment versus monotherapy in mild-to-moderate stable plaque psoriasis (SPP). The objective of this study was to compare the safety and efficacy of topical sequential treatment with tazarotene followed by calcitriol, topical calcitriol followed by tazarotene, tazarotene monotherapy, calcitriol monotherapy, and compare the safety and efficacy of the sequential therapies with monotherapies.

Methods: The study was a single center, prospective parallel-group, active control, randomized study of 16 weeks duration (treatment for 8 weeks and follow-up for 16 weeks), randomized to either of the four groups, i.e., tazarotene 0.1% for 4 weeks followed by calcitriol 0.0003% for 4 weeks or calcitriol 0.0003% for 4 weeks followed by tazarotene 0.1% for 4 weeks or tazarotene 0.1% for 8 weeks or calcitriol 0.0003% for 8 weeks. Both tazarotene and calcitriol were applied once daily in all the groups.

Findings: There was no significant difference with regard to age and duration of illness among the four treatment groups. Statistically significant improvement was observed in erythema, scaling, and induration scores, and Physician`s global assessment scale at 8 weeks and 16 weeks as compared to baseline in tazarotene - calcitriol, calcitriol - tazarotene, and calcitriol versus tazarotene groups.

Conclusion: This study concluded that topical treatment with tazarotene 0.1% and calcitriol 0.003% was efficacious in treating mild-to-moderate SPP as both sequential and monotherapy. However, topical treatment with tazarotene as monotherapy was the least efficacious.

目的:银屑病是一种导致皮肤细胞快速更替的自身免疫性疾病。它是一种慢性疾病,严重影响患者的生活质量,通常需要长期治疗。因此,我们设计了这项研究,以比较在轻度至中度稳定型斑块状银屑病(SPP)中使用 0.1% 他扎罗汀乳膏和 0.0003% 降钙三醇软膏进行序贯疗法与单一疗法的安全性和有效性。本研究的目的是比较他扎罗汀和降钙素三醇外用序贯疗法、他扎罗汀和降钙素三醇外用序贯疗法、他扎罗汀单药疗法和降钙素三醇单药疗法的安全性和有效性,并比较序贯疗法和单药疗法的安全性和有效性:该研究是一项单中心、前瞻性、平行组、主动对照、随机研究,为期16周(治疗8周,随访16周),随机分为四组,即他扎罗汀0.1%治疗4周,然后降钙素三醇0.0003%治疗4周,或降钙素三醇0.0003%治疗4周,然后他扎罗汀0.1%治疗4周,或他扎罗汀0.1%治疗8周,或降钙素三醇0.0003%治疗8周。所有治疗组的他扎罗汀和降钙素三醇均每天使用一次:结果:四个治疗组在年龄和病程方面没有明显差异。与基线相比,他扎罗汀-方解三醇组、方解三醇-他扎罗汀组和方解三醇对他扎罗汀组在8周和16周时的红斑、脱屑和压痕评分以及医生总体评估量表均有统计学意义的明显改善:本研究得出结论:他扎罗汀 0.1%和降钙素三醇 0.003% 的外用疗法对治疗轻度至中度 SPP 均有疗效。然而,他扎罗汀单药外用治疗的疗效最差。
{"title":"Head-to-Head Comparison of Tazarotene and Calcitriol with or without Sequential Therapy in Mild-to-Moderate Psoriasis: A Randomized Open-label Study.","authors":"Jaspreet Kaur Sidhu, Prithpal Singh Matreja, Ashwani Kumar Gupta, Amandeep Singh, Surjit Singh","doi":"10.4103/jrpp.jrpp_10_23","DOIUrl":"10.4103/jrpp.jrpp_10_23","url":null,"abstract":"<p><strong>Objective: </strong>Psoriasis is an autoimmune disease that causes rapid turnover of skin cells. It is a chronic disease that affects a patient's quality of life significantly and frequently requires long-term treatment. The study on sequential therapy with tazarotene 0.1% and calcitriol 0.0003% has not been tried so far; hence, we designed this study to compare the safety and efficacy of sequential therapy with tazarotene 0.1% cream and calcitriol 0.0003% ointment versus monotherapy in mild-to-moderate stable plaque psoriasis (SPP). The objective of this study was to compare the safety and efficacy of topical sequential treatment with tazarotene followed by calcitriol, topical calcitriol followed by tazarotene, tazarotene monotherapy, calcitriol monotherapy, and compare the safety and efficacy of the sequential therapies with monotherapies.</p><p><strong>Methods: </strong>The study was a single center, prospective parallel-group, active control, randomized study of 16 weeks duration (treatment for 8 weeks and follow-up for 16 weeks), randomized to either of the four groups, i.e., tazarotene 0.1% for 4 weeks followed by calcitriol 0.0003% for 4 weeks or calcitriol 0.0003% for 4 weeks followed by tazarotene 0.1% for 4 weeks or tazarotene 0.1% for 8 weeks or calcitriol 0.0003% for 8 weeks. Both tazarotene and calcitriol were applied once daily in all the groups.</p><p><strong>Findings: </strong>There was no significant difference with regard to age and duration of illness among the four treatment groups. Statistically significant improvement was observed in erythema, scaling, and induration scores, and Physician`s global assessment scale at 8 weeks and 16 weeks as compared to baseline in tazarotene - calcitriol, calcitriol - tazarotene, and calcitriol versus tazarotene groups.</p><p><strong>Conclusion: </strong>This study concluded that topical treatment with tazarotene 0.1% and calcitriol 0.003% was efficacious in treating mild-to-moderate SPP as both sequential and monotherapy. However, topical treatment with tazarotene as monotherapy was the least efficacious.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 2","pages":"44-48"},"PeriodicalIF":1.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients. 吸烟习惯对男性患者氯氮平与诺氯氮平比例的影响
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_37_23
Roberto Lozano, Carina Bona

Objective: This study aimed to evaluate the influence of cigarette smoking habit on the clozapine (CLZ)-to-norclozapine (norCLZ) ratio in male patients.

Methods: The sample consisted of plasma concentration of CLZ and norCLZ data set. The mean values of CLZ, norCLZ, and CLZ-to-norCLZ, between male patients who smoke versus nonsmokers were compared.

Findings: CLZ mean plasma level of 142 ± 80 ng/ml and 305 ± 159 ng/ml, norCLZ mean plasma level of 93 ± 72 ng/ml and 234 ± 62 ng/ml, and mean CLZ-to-norCLZ plasma level ratio of 2.1 ± 1.1 and 1.5 ± 0.5, were obtained respectively for male patients who smoke and nonsmokers.

Conclusion: This study has shown a significant decrease in CLZ and norCLZ plasma levels, and an increase in the CLZ-to-norCLZ ratio, in smokers as compared to nonsmokers, due to an increase in the clearance of CLZ and norCLZ by smoking induction of CYP 1A2 and glucuronidation by uridyl glucuronyl transferase enzymes (UGT), mainly UGT 1A4, respectively, as the most probable cause.

研究目的本研究旨在评估吸烟习惯对男性患者氯氮平(CLZ)-去氯氮平(norCLZ)比值的影响:样本包括CLZ和norCLZ的血浆浓度数据集。比较了吸烟与不吸烟男性患者的 CLZ、norCLZ 和 CLZ 与 norCLZ 的平均值:结果:吸烟和不吸烟男性患者的 CLZ 平均血浆水平分别为 142 ± 80 ng/ml 和 305 ± 159 ng/ml,norCLZ 平均血浆水平分别为 93 ± 72 ng/ml 和 234 ± 62 ng/ml,CLZ 与 norCLZ 平均血浆水平比分别为 2.1 ± 1.1 和 1.5 ± 0.5:本研究表明,与不吸烟者相比,吸烟者的CLZ和norCLZ血浆水平明显下降,CLZ与norCLZ的比值上升,这可能是由于吸烟分别诱导CYP 1A2和尿苷葡萄糖醛酸转移酶(UGT)(主要是UGT 1A4)的葡萄糖醛酸化作用,从而增加了CLZ和norCLZ的清除率。
{"title":"Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients.","authors":"Roberto Lozano, Carina Bona","doi":"10.4103/jrpp.jrpp_37_23","DOIUrl":"10.4103/jrpp.jrpp_37_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the influence of cigarette smoking habit on the clozapine (CLZ)-to-norclozapine (norCLZ) ratio in male patients.</p><p><strong>Methods: </strong>The sample consisted of plasma concentration of CLZ and norCLZ data set. The mean values of CLZ, norCLZ, and CLZ-to-norCLZ, between male patients who smoke versus nonsmokers were compared.</p><p><strong>Findings: </strong>CLZ mean plasma level of 142 ± 80 ng/ml and 305 ± 159 ng/ml, norCLZ mean plasma level of 93 ± 72 ng/ml and 234 ± 62 ng/ml, and mean CLZ-to-norCLZ plasma level ratio of 2.1 ± 1.1 and 1.5 ± 0.5, were obtained respectively for male patients who smoke and nonsmokers.</p><p><strong>Conclusion: </strong>This study has shown a significant decrease in CLZ and norCLZ plasma levels, and an increase in the CLZ-to-norCLZ ratio, in smokers as compared to nonsmokers, due to an increase in the clearance of CLZ and norCLZ by smoking induction of CYP 1A2 and glucuronidation by uridyl glucuronyl transferase enzymes (UGT), mainly UGT 1A4, respectively, as the most probable cause.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"29-31"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxicoepidemiology of Phosphide Poisoning in the Central Part of Iran. 伊朗中部地区磷化氢中毒的毒物流行病学。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_20_23
Nastaran Eizadi-Mood, Mahnaz Momenzadeh, Masoumeh Sadeghi, Ahmad Yaraghi, Ali Mohammad Sabzghabaee, Sam Alfred

Objective: Aluminum phosphide (ALP) and zinc phosphide (ZnP) are toxic agrochemical pesticides, which are commonly used as an agent of self-harm in developing countries. Because of high toxicity of phosphides, we evaluated toxico-epidemiology ALP and ZnP poisoning in with respect to outcome.

Methods: We performed a cross-sectional study with retrospective chart review including the records for patients admitted due to phosphide poisoning (ALP, ZnP) in a poisoning referral center in Khorshid Hospital, affiliated with Isfahan University of Medial Sciences, Isfahan, Iran. Demographic characteristics, clinical manifestations, outcome (survived or death), and length of hospital stay for the patients were recorded in a data collecting form. Binary backward stepwise logistic regression was used for outcome prediction.

Findings: Sixty patients were evaluated in the study. The mean age of patients was 27.61. Thirty-nine patients were men. 96.7% of the patients ingested it intentionally. Most of the patients on admission were conscious (66.7%). Abnormality of EKG was noted in 8.3%. The mortality in ALP and ZnP poisoning was 39.2% and 22.2%, respectively. Serum bicarbonate and base excess in the venous blood gas analysis, systolic blood pressure, and serum sodium level were significantly different between patients with ALP and ZnP poisoning on admission time (P < 0.05). On admission, systolic blood pressure was an important predictive factor for mortality (odds ratio 4.87; 95% confidence interval: 1.5-15.45; P = 0.007).

Conclusion: The rate of mortality in phosphide poisoning is high. Knowing predictive factors for mortality help physicians for selecting patients in intensive care unit admission and aggressive treatment.

目的:磷化铝(ALP)和磷化锌(ZnP)是有毒的农用化学杀虫剂,在发展中国家通常被用作自残剂。由于磷化物的毒性很高,我们对 ALP 和 ZnP 中毒的毒物流行病学结果进行了评估:我们在伊朗伊斯法罕市伊斯法罕医科大学附属 Khorshid 医院的中毒转诊中心开展了一项横断面研究,并对磷化物中毒(ALP 和 ZnP)患者的病历进行了回顾性病历审查。患者的人口统计学特征、临床表现、结果(存活或死亡)和住院时间均记录在数据收集表中。结果预测采用二元后向逐步逻辑回归法:研究共评估了 60 名患者。患者的平均年龄为 27.61 岁。39 名患者为男性。96.7%的患者为故意摄入。大多数患者入院时神志清醒(66.7%)。8.3%的患者心电图异常。ALP 和锌粉中毒的死亡率分别为 39.2% 和 22.2%。静脉血气分析中的血清碳酸氢盐和碱过量、收缩压和血清钠水平在 ALP 和锌中毒患者入院时有显著差异(P < 0.05)。入院时,收缩压是预测死亡率的重要因素(几率比4.87;95%置信区间:1.5-15.45;P = 0.007):结论:磷化氢中毒的死亡率很高。结论:磷化氢中毒的死亡率很高,了解死亡率的预测因素有助于医生选择重症监护室收治的患者并进行积极治疗。
{"title":"Toxicoepidemiology of Phosphide Poisoning in the Central Part of Iran.","authors":"Nastaran Eizadi-Mood, Mahnaz Momenzadeh, Masoumeh Sadeghi, Ahmad Yaraghi, Ali Mohammad Sabzghabaee, Sam Alfred","doi":"10.4103/jrpp.jrpp_20_23","DOIUrl":"10.4103/jrpp.jrpp_20_23","url":null,"abstract":"<p><strong>Objective: </strong>Aluminum phosphide (ALP) and zinc phosphide (ZnP) are toxic agrochemical pesticides, which are commonly used as an agent of self-harm in developing countries. Because of high toxicity of phosphides, we evaluated toxico-epidemiology ALP and ZnP poisoning in with respect to outcome.</p><p><strong>Methods: </strong>We performed a cross-sectional study with retrospective chart review including the records for patients admitted due to phosphide poisoning (ALP, ZnP) in a poisoning referral center in Khorshid Hospital, affiliated with Isfahan University of Medial Sciences, Isfahan, Iran. Demographic characteristics, clinical manifestations, outcome (survived or death), and length of hospital stay for the patients were recorded in a data collecting form. Binary backward stepwise logistic regression was used for outcome prediction.</p><p><strong>Findings: </strong>Sixty patients were evaluated in the study. The mean age of patients was 27.61. Thirty-nine patients were men. 96.7% of the patients ingested it intentionally. Most of the patients on admission were conscious (66.7%). Abnormality of EKG was noted in 8.3%. The mortality in ALP and ZnP poisoning was 39.2% and 22.2%, respectively. Serum bicarbonate and base excess in the venous blood gas analysis, systolic blood pressure, and serum sodium level were significantly different between patients with ALP and ZnP poisoning on admission time (<i>P</i> < 0.05). On admission, systolic blood pressure was an important predictive factor for mortality (odds ratio 4.87; 95% confidence interval: 1.5-15.45; <i>P</i> = 0.007).</p><p><strong>Conclusion: </strong>The rate of mortality in phosphide poisoning is high. Knowing predictive factors for mortality help physicians for selecting patients in intensive care unit admission and aggressive treatment.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"21-28"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Presence of the Joint Commission International Accreditation Requirements in Western Saudi Arabia Hospital Pharmacies: A Cross-sectional Study. 评估沙特阿拉伯西部医院药房是否符合国际联合委员会评审要求:横断面研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_5_23
Ahmed Ibrahim Fathelrahman, Huda Abdullah Almalki, Hanan Rashad Bajunaid, Ghaidaa Khalid Al-Harthi, Manal Omar Aljuaid, Ruqayyah Yahya Majrashi, Mohammed Abdullah Alsuwat

Objective: The Central Board of Accreditation for Healthcare Institutions (CBAHI) the national Saudi accreditation body accredited most hospitals in Saudi Arabia whereas, the Joint Commission International (JCI) a well-known international accreditation body accredited some hospitals. We assessed Western Saudi Arabia hospital pharmacists' knowledge, opinions, and observations about pharmacy-related JCI accreditation criteria needed for hospitals.

Methods: This was a cross-sectional survey-based study conducted among pharmacy personnel working in the Ministry of Health (MOH), Military, and private hospitals in the Makkah region in western Saudi Arabia. The present report represents the findings of descriptive and comparative analyses. Comparative analyses were tested by Student's t-test, analysis of variance, and Chi-square when applicable and a P ≤ 0.05 was considered statistically significant.

Findings: One hundred and one pharmacists completed the survey; most of them were from Taif (53.5%) and Jeddah (37.6%) and fewer from Makkah (8.9%). The highest proportions were from MOH (55.4%), private (29.7%), and some from military (14.9%) hospitals. They worked mostly in hospitals accredited with CBAHI (93.1%) than JCI (58.4%) and only (41.6%) worked with quality units. Correct answers on knowledge items ranged from 14.9% to 65.3%. On five-point Likert Scale, they showed supportive ratings on how they perceived the importance of JCI statement provided (overall average score: 3.78) and on how statement criteria are implemented in their hospitals (overall average score: 3.76). Higher proportions of those working in quality units compared to their counterparts were aware that accreditation cycles for JCI and CBAHI are identical (66.7% vs. 55.9%, P = 0.009) and that JCI criteria are more concise than CBAHI (59.5% vs. 52.5%, P = 0.007). Higher proportions of those working in JCI-accredited hospitals compared to their counterparts were aware that JCI criteria are clearer than CBAHI (55.9% vs. 33.3%, P = 0.021) and that JCI criteria are more concise than CBAHI (61% vs. 47.6%, P = 0.012).

Conclusion: To a high extent, pharmacists were supportive of JCI criteria and considered the criteria to be implemented in their hospitals. There is a room for improvement to enhance awareness and support of JCI quality criteria among pharmacists.

目的:沙特阿拉伯的国家评审机构--医疗机构评审中央委员会(CBAHI)对沙特阿拉伯的大多数医院进行了评审,而著名的国际评审机构--国际联合委员会(JCI)则对一些医院进行了评审。我们评估了沙特阿拉伯西部医院药剂师对医院所需的与药剂相关的 JCI 评审标准的了解、看法和意见:这是一项基于横断面调查的研究,研究对象是在沙特阿拉伯西部麦加地区的卫生部 (MOH)、军队和私立医院工作的药剂师。本报告是描述性分析和比较分析的结果。比较分析采用学生 t 检验、方差分析,适当时采用卡方检验,P ≤ 0.05 为有统计学意义:101 名药剂师完成了调查,其中大部分来自塔伊夫(53.5%)和吉达(37.6%),麦加的药剂师较少(8.9%)。来自卫生部(55.4%)、私立医院(29.7%)和军队医院(14.9%)的比例最高。他们大多在获得 CBAHI(93.1%)认证的医院工作,而不是 JCI(58.4%)认证的医院,只有(41.6%)在质量单位工作。知识项目的正确答案从 14.9% 到 65.3% 不等。在五点李克特量表中,他们对所提供的 JCI 声明的重要性(总平均分:3.78)和声明标准在医院中的实施情况(总平均分:3.76)均表示支持。与同行相比,在质量部门工作的人员中有更高比例的人知道 JCI 和 CBAHI 的评审周期相同(66.7% 对 55.9%,P = 0.009),而且 JCI 标准比 CBAHI 更简洁(59.5% 对 52.5%,P = 0.007)。在通过 JCI 认证的医院工作的药剂师中,知道 JCI 标准比 CBAHI 标准更清晰(55.9% 对 33.3%,P = 0.021)以及 JCI 标准比 CBAHI 标准更简洁(61% 对 47.6%,P = 0.012)的药剂师比例高于其他药剂师:结论:药剂师在很大程度上支持 JCI 标准,并认为应在其所在医院实施该标准。在提高药剂师对 JCI 质量标准的认识和支持方面还有待改进。
{"title":"Assessing the Presence of the Joint Commission International Accreditation Requirements in Western Saudi Arabia Hospital Pharmacies: A Cross-sectional Study.","authors":"Ahmed Ibrahim Fathelrahman, Huda Abdullah Almalki, Hanan Rashad Bajunaid, Ghaidaa Khalid Al-Harthi, Manal Omar Aljuaid, Ruqayyah Yahya Majrashi, Mohammed Abdullah Alsuwat","doi":"10.4103/jrpp.jrpp_5_23","DOIUrl":"10.4103/jrpp.jrpp_5_23","url":null,"abstract":"<p><strong>Objective: </strong>The Central Board of Accreditation for Healthcare Institutions (CBAHI) the national Saudi accreditation body accredited most hospitals in Saudi Arabia whereas, the Joint Commission International (JCI) a well-known international accreditation body accredited some hospitals. We assessed Western Saudi Arabia hospital pharmacists' knowledge, opinions, and observations about pharmacy-related JCI accreditation criteria needed for hospitals.</p><p><strong>Methods: </strong>This was a cross-sectional survey-based study conducted among pharmacy personnel working in the Ministry of Health (MOH), Military, and private hospitals in the Makkah region in western Saudi Arabia. The present report represents the findings of descriptive and comparative analyses. Comparative analyses were tested by Student's <i>t</i>-test, analysis of variance, and Chi-square when applicable and a <i>P</i> ≤ 0.05 was considered statistically significant.</p><p><strong>Findings: </strong>One hundred and one pharmacists completed the survey; most of them were from Taif (53.5%) and Jeddah (37.6%) and fewer from Makkah (8.9%). The highest proportions were from MOH (55.4%), private (29.7%), and some from military (14.9%) hospitals. They worked mostly in hospitals accredited with CBAHI (93.1%) than JCI (58.4%) and only (41.6%) worked with quality units. Correct answers on knowledge items ranged from 14.9% to 65.3%. On five-point Likert Scale, they showed supportive ratings on how they perceived the importance of JCI statement provided (overall average score: 3.78) and on how statement criteria are implemented in their hospitals (overall average score: 3.76). Higher proportions of those working in quality units compared to their counterparts were aware that accreditation cycles for JCI and CBAHI are identical (66.7% vs. 55.9%, <i>P</i> = 0.009) and that JCI criteria are more concise than CBAHI (59.5% vs. 52.5%, <i>P</i> = 0.007). Higher proportions of those working in JCI-accredited hospitals compared to their counterparts were aware that JCI criteria are clearer than CBAHI (55.9% vs. 33.3%, <i>P</i> = 0.021) and that JCI criteria are more concise than CBAHI (61% vs. 47.6%, <i>P</i> = 0.012).</p><p><strong>Conclusion: </strong>To a high extent, pharmacists were supportive of JCI criteria and considered the criteria to be implemented in their hospitals. There is a room for improvement to enhance awareness and support of JCI quality criteria among pharmacists.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"1-8"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139424982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Current Community Pharmacist Practice in Saudi Arabia: A Cross-sectional Study from Patients' Perspective (PART I). 沙特阿拉伯当前社区药剂师实践评估:从患者角度进行的横断面研究(第一部分)。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_12_23
Abdulmajeed Bajuayfir, Mohammad Alhazmi, Omar Alshareef, Ahmed Rawas, Sumayyah Alsharif, Amal Almasoudi, Ejaz Cheema, Majid Ali

Objective: This study aimed to evaluate the current practice of community pharmacists from patients' and pharmacists' perspectives in Saudi Arabia. This paper presents the patients' perspective.

Methods: A self-administered cross-sectional survey was developed to collect responses from patients in Saudi Arabia from February to April 2021. The questionnaire comprised several statements related to the best practice in community pharmacy. Patients' responses to each statement were scored using a 5-point Likert scale. Higher scores represented the greater extent to which the pharmacists perform the best practice in a community pharmacy setting and vice versa.

Findings: The data of 233 participants were included in the analysis. The majority of the participants were female (67%) and Saudi nationals (96%). The minimum mean score was related to the statement: pharmacist discusses with you about herbal medications or vitamin supplements. The maximum mean score was related to the statement: Pharmacist explains to you about the dose of medications and when to take them. Participants who were <20 years old had a significantly highest mean score, whereas those above 40 years old had the least mean score, P = 0.001. Participants from the Eastern region had a significantly highest mean score, compared to South region participants who had the least mean score, P = 0.009.

Conclusion: A gap in the current practice and the best practice of community pharmacists was found. The policymakers can utilize these findings to provide targeted professional development opportunities for the practicing community pharmacists to improve the overall service and care for the patients.

研究目的本研究旨在从患者和药剂师的角度评估沙特阿拉伯社区药剂师的现行做法。本文将从患者的角度进行阐述:2021 年 2 月至 4 月期间,在沙特阿拉伯开展了一项自填式横断面调查,以收集患者的答复。问卷包括与社区药房最佳实践相关的几项陈述。患者对每项陈述的回答均采用 5 点李克特量表进行评分。得分越高,表示药剂师在社区药房环境中执行最佳实践的程度越高,反之亦然:共有 233 名参与者的数据被纳入分析。大部分参与者为女性(67%)和沙特国民(96%)。最低平均得分与以下陈述有关:药剂师与您讨论草药或维生素补充剂。最高平均分与以下陈述有关:药剂师向您解释药物的剂量和服用时间。P = 0.001。东部地区参与者的平均得分明显最高,而南部地区参与者的平均得分最低,P = 0.009:发现社区药剂师目前的实践与最佳实践之间存在差距。政策制定者可利用这些研究结果,为执业社区药剂师提供有针对性的专业发展机会,以改善对患者的整体服务和护理。
{"title":"Evaluation of Current Community Pharmacist Practice in Saudi Arabia: A Cross-sectional Study from Patients' Perspective (PART I).","authors":"Abdulmajeed Bajuayfir, Mohammad Alhazmi, Omar Alshareef, Ahmed Rawas, Sumayyah Alsharif, Amal Almasoudi, Ejaz Cheema, Majid Ali","doi":"10.4103/jrpp.jrpp_12_23","DOIUrl":"10.4103/jrpp.jrpp_12_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the current practice of community pharmacists from patients' and pharmacists' perspectives in Saudi Arabia. This paper presents the patients' perspective.</p><p><strong>Methods: </strong>A self-administered cross-sectional survey was developed to collect responses from patients in Saudi Arabia from February to April 2021. The questionnaire comprised several statements related to the best practice in community pharmacy. Patients' responses to each statement were scored using a 5-point Likert scale. Higher scores represented the greater extent to which the pharmacists perform the best practice in a community pharmacy setting and vice versa.</p><p><strong>Findings: </strong>The data of 233 participants were included in the analysis. The majority of the participants were female (67%) and Saudi nationals (96%). The minimum mean score was related to the statement: pharmacist discusses with you about herbal medications or vitamin supplements. The maximum mean score was related to the statement: Pharmacist explains to you about the dose of medications and when to take them. Participants who were <20 years old had a significantly highest mean score, whereas those above 40 years old had the least mean score, <i>P</i> = 0.001. Participants from the Eastern region had a significantly highest mean score, compared to South region participants who had the least mean score, <i>P</i> = 0.009.</p><p><strong>Conclusion: </strong>A gap in the current practice and the best practice of community pharmacists was found. The policymakers can utilize these findings to provide targeted professional development opportunities for the practicing community pharmacists to improve the overall service and care for the patients.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"15-20"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1